Viz IPO

Viz.ai develops artificial intelligence software for medical imaging analysis, with a primary focus on stroke detection and care coordination. The company's FDA-cleared platform analyzes CT scans in real-time to identify suspected large vessel occlusion strokes, automatically notifying specialist stroke teams and potentially life-saving interventions. The technology significantly reduces the time from imaging to treatment decision, which is critical in stroke care where 'time is brain.'

Beyond stroke detection, Viz has expanded its AI platform to identify other time-sensitive conditions including pulmonary embolism, aortic dissection, and cerebral aneurysms. The company's software integrates directly into hospital imaging workflows and has been deployed across hundreds of hospitals and health systems. Viz's approach combines computer vision AI with care coordination tools, creating a comprehensive platform that not only detects critical conditions but also facilitates rapid clinical response and treatment.